332 related articles for article (PubMed ID: 25712719)
1. Mineralocorticoid receptor antagonism treats obesity-associated cardiac diastolic dysfunction.
Bender SB; DeMarco VG; Padilla J; Jenkins NT; Habibi J; Garro M; Pulakat L; Aroor AR; Jaffe IZ; Sowers JR
Hypertension; 2015 May; 65(5):1082-8. PubMed ID: 25712719
[TBL] [Abstract][Full Text] [Related]
2. Mineralocorticoid receptor blockade prevents Western diet-induced diastolic dysfunction in female mice.
Bostick B; Habibi J; DeMarco VG; Jia G; Domeier TL; Lambert MD; Aroor AR; Nistala R; Bender SB; Garro M; Hayden MR; Ma L; Manrique C; Sowers JR
Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1126-35. PubMed ID: 25747754
[TBL] [Abstract][Full Text] [Related]
3. Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling.
Stas S; Whaley-Connell A; Habibi J; Appesh L; Hayden MR; Karuparthi PR; Qazi M; Morris EM; Cooper SA; Link CD; Stump C; Hay M; Ferrario C; Sowers JR
Endocrinology; 2007 Aug; 148(8):3773-80. PubMed ID: 17494996
[TBL] [Abstract][Full Text] [Related]
4. Paradoxical mineralocorticoid receptor activation and left ventricular diastolic dysfunction under high oxidative stress conditions.
Wang H; Shimosawa T; Matsui H; Kaneko T; Ogura S; Uetake Y; Takenaka K; Yatomi Y; Fujita T
J Hypertens; 2008 Jul; 26(7):1453-62. PubMed ID: 18551023
[TBL] [Abstract][Full Text] [Related]
5. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and prevents oxidative stress in uremic rats.
Michea L; Villagrán A; Urzúa A; Kuntsmann S; Venegas P; Carrasco L; Gonzalez M; Marusic ET
Hypertension; 2008 Aug; 52(2):295-300. PubMed ID: 18591458
[TBL] [Abstract][Full Text] [Related]
6. Spironolactone alleviates late cardiac remodeling after left ventricular restoration surgery.
Tsukashita M; Marui A; Nishina T; Yoshikawa E; Kanemitsu H; Wang J; Ikeda T; Komeda M
J Thorac Cardiovasc Surg; 2008 Jul; 136(1):58-64. PubMed ID: 18603054
[TBL] [Abstract][Full Text] [Related]
7. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats.
Nagata K; Obata K; Xu J; Ichihara S; Noda A; Kimata H; Kato T; Izawa H; Murohara T; Yokota M
Hypertension; 2006 Apr; 47(4):656-64. PubMed ID: 16505208
[TBL] [Abstract][Full Text] [Related]
8. Mineralocorticoid receptor antagonism reverses diabetes-related coronary vasodilator dysfunction: A unique vascular transcriptomic signature.
Brown SM; Meuth AI; Davis JW; Rector RS; Bender SB
Pharmacol Res; 2018 Aug; 134():100-108. PubMed ID: 29870805
[TBL] [Abstract][Full Text] [Related]
9. Aldosterone receptor blockade prevents the transition to cardiac pump dysfunction induced by beta-adrenoreceptor activation.
Veliotes DG; Woodiwiss AJ; Deftereos DA; Gray D; Osadchii O; Norton GR
Hypertension; 2005 May; 45(5):914-20. PubMed ID: 15837836
[TBL] [Abstract][Full Text] [Related]
10. Fibrosis and cardiac function in obesity: a randomised controlled trial of aldosterone blockade.
Kosmala W; Przewlocka-Kosmala M; Szczepanik-Osadnik H; Mysiak A; Marwick TH
Heart; 2013 Mar; 99(5):320-6. PubMed ID: 23343682
[TBL] [Abstract][Full Text] [Related]
11. Low-Dose Mineralocorticoid Receptor Blockade Prevents Western Diet-Induced Arterial Stiffening in Female Mice.
DeMarco VG; Habibi J; Jia G; Aroor AR; Ramirez-Perez FI; Martinez-Lemus LA; Bender SB; Garro M; Hayden MR; Sun Z; Meininger GA; Manrique C; Whaley-Connell A; Sowers JR
Hypertension; 2015 Jul; 66(1):99-107. PubMed ID: 26015449
[TBL] [Abstract][Full Text] [Related]
12. Effects of salt status and blockade of mineralocorticoid receptors on aldosterone-induced cardiac injury.
Hattori T; Murase T; Sugiura Y; Nagasawa K; Takahashi K; Ohtake M; Ohtake M; Miyachi M; Murohara T; Nagata K
Hypertens Res; 2014 Feb; 37(2):125-33. PubMed ID: 24048492
[TBL] [Abstract][Full Text] [Related]
13. Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure.
Mottram PM; Haluska B; Leano R; Cowley D; Stowasser M; Marwick TH
Circulation; 2004 Aug; 110(5):558-65. PubMed ID: 15277317
[TBL] [Abstract][Full Text] [Related]
14. Spironolactone prevents alterations associated with cardiac hypertrophy produced by isoproterenol in rats: involvement of serum- and glucocorticoid-regulated kinase type 1.
Martín-Fernández B; de las Heras N; Miana M; Ballesteros S; Valero-Muñoz M; Vassallo D; Davel AP; Rossoni LV; Cachofeiro V; Lahera V
Exp Physiol; 2012 Jun; 97(6):710-8. PubMed ID: 22327331
[TBL] [Abstract][Full Text] [Related]
15. Mineralocorticoid receptor antagonism attenuates glomerular filtration barrier remodeling in the transgenic Ren2 rat.
Whaley-Connell A; Habibi J; Wei Y; Gutweiler A; Jellison J; Wiedmeyer CE; Ferrario CM; Sowers JR
Am J Physiol Renal Physiol; 2009 May; 296(5):F1013-22. PubMed ID: 19261739
[TBL] [Abstract][Full Text] [Related]
16. Mineralocorticoid receptor blockade improves diastolic function independent of blood pressure reduction in a transgenic model of RAAS overexpression.
Habibi J; DeMarco VG; Ma L; Pulakat L; Rainey WE; Whaley-Connell AT; Sowers JR
Am J Physiol Heart Circ Physiol; 2011 Apr; 300(4):H1484-91. PubMed ID: 21239636
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid-induced hypertension and cardiac injury: effects of mineralocorticoid and glucocorticoid receptor antagonism.
Hattori T; Murase T; Iwase E; Takahashi K; Ohtake M; Tsuboi K; Ohtake M; Miyachi M; Murohara T; Nagata K
Nagoya J Med Sci; 2013 Feb; 75(1-2):81-92. PubMed ID: 23544271
[TBL] [Abstract][Full Text] [Related]
18. Multi-omic analysis of the cardiac cellulome defines a vascular contribution to cardiac diastolic dysfunction in obese female mice.
Dona MSI; Hsu I; Meuth AI; Brown SM; Bailey CA; Aragonez CG; Russell JJ; Krstevski C; Aroor AR; Chandrasekar B; Martinez-Lemus LA; DeMarco VG; Grisanti LA; Jaffe IZ; Pinto AR; Bender SB
Basic Res Cardiol; 2023 Mar; 118(1):11. PubMed ID: 36988733
[TBL] [Abstract][Full Text] [Related]
19. Salt excess causes left ventricular diastolic dysfunction in rats with metabolic disorder.
Matsui H; Ando K; Kawarazaki H; Nagae A; Fujita M; Shimosawa T; Nagase M; Fujita T
Hypertension; 2008 Aug; 52(2):287-94. PubMed ID: 18606904
[TBL] [Abstract][Full Text] [Related]
20. Spironolactone preserves cardiac norepinephrine reuptake in salt-sensitive Dahl rats.
Buss SJ; Backs J; Kreusser MM; Hardt SE; Maser-Gluth C; Katus HA; Haass M
Endocrinology; 2006 May; 147(5):2526-34. PubMed ID: 16439456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
